Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
作者信息
Belardi Jorge
出版信息
Catheter Cardiovasc Interv. 2008 Apr 1;71(5):599. doi: 10.1002/ccd.21568.
PMID:18360848
Abstract
摘要
相似文献
1
Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
Catheter Cardiovasc Interv. 2008 Apr 1;71(5):599. doi: 10.1002/ccd.21568.
2
Drug-eluting stent in saphenous vein graft lesions.
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):894-5. doi: 10.1002/ccd.21615.
3
Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Catheter Cardiovasc Interv. 2008 Apr 1;71(5):594-8. doi: 10.1002/ccd.21399.
4
Long-term follow-up of the First In Man experience with everolimus-eluting stents.
Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1004-5. doi: 10.1002/ccd.22629.
5
Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):886-93. doi: 10.1002/ccd.21552.
6
Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents.
Catheter Cardiovasc Interv. 2007 Aug 1;70(2):184. doi: 10.1002/ccd.21293.
7
Are we totally clear?
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):987-8. doi: 10.1002/ccd.22335.
8
Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):944-9. doi: 10.1002/ccd.21731.
9
The long-term results of the "Endeavor" stent.
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):996-9. doi: 10.1002/ccd.22334.
10
What kind of stent for you today and how would you like it prepared?
Catheter Cardiovasc Interv. 2007 Aug 1;70(2):173-4. doi: 10.1002/ccd.21288.
Zotero 插件